Identification of an Immune-Related BAT Signature for Predicting Adjuvant Chemotherapy Response and Overall Survival in Patients with Resected Ductal Adenocarcinoma of the Pancreas.

Ning PuQiangda ChenHanlin YinJicheng ZhangGuochao ZhaoJoseph R HabibJie ChenJun YuWenhui LouWenchuan Wu

Published in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2022)

The BAT signature is a novel formulated and independent risk factor for predicting ACT response and long-term survival in patients with resected PDAC. This signature could comprehensively reflect local immune-related response, tumor purity, potential biological behavior, and chemo drug susceptibility.

Keyphrases

lymph node
squamous cell carcinoma
photodynamic therapy
emergency department
risk assessment
radiation therapy
drug delivery
cancer therapy
climate change